Clinical Research Facility
415 Curie Boulevard
Philiadelphia, Pennsylvania 19104

Use our guide to learn which trials are right for you!

We've found
1 trials
at this facility
Head and Neck Squamous Cell Carcinoma HNSCC Clinical Trial
Study of MK-3475 (Pembrolizumab) in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma After Treatment With Platinum-based and Cetuximab Therapy (MK-3475-055/KEYNOTE-055)
Status: Enrolling, Phase II
Updated: 9/23/2015
Clinical Research Facility
mi
from
Philiadelphia, PA
Click here to add this to my saved trials